glp-1 news oct 9 2025 Trends: Access & Shortages, Insurance Coverage & More GLP-1 Weight-Loss Drug Demonstration Begins

The analysts in a Tuesday note caveated that China-specific trials tend to generate less profound weight loss relative to global studies, primarily driven by lower BMI and higher proportion of male participants (though we recognize that the proportion of females was similar between HARBOR-1 and ATTAIN-1). After this data drop, Hengrui said it plans on submitting new drug applications (NDAs) in both obesity and type 2 diabetes in China, according to a Tuesday release

Standard Therapeutic Dosages Studies show that 500 to 2000 mcg of methylcobalamin works well for neuropathy

Check with your healthcare provider

Ploy Pitayanon, MD, licensed by the Medical Council of Thailand At a Glance Peptide Ipamorelin Category Longevity Dosage 200 to 300 mcg per injection, physician-prescribed